Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort.
Ramonda R, Lorenzin M, Chimenti MS, Atzeni F, Semeraro A, D'Angelo S, Selmi C, Ortolan A, Marchesoni A, Manara M, Luchetti Gentiloni MM, Santo L, Salvarani C, Cauli A, Rossini M, Amato G, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Fracassi E, Giorgio F, Doria A, Foti R, Carletto A; on behalf Spondyloarthritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”.
Ramonda R, et al. Among authors: atzeni f.
Arthritis Res Ther. 2024 Sep 28;26(1):172. doi: 10.1186/s13075-024-03401-x.
Arthritis Res Ther. 2024.
PMID: 39342310
Free PMC article.